Fig. 2
Forest plots illustrating the relationship between CYP3A4 genetic variants and tacrolimus pharmacokinetics. A Weight-adjusted daily dose of CYP3A4*1/*1 carriers versus CYP3A4*22 carriers at different post-transplantation time courses; B C0/Dose of CYP3A4*1/*1 carriers versus CYP3A4*22 carriers at different post-transplantation time courses. C0/Dose: dose-adjusted trough concentration; NR: not reported; WMD: weighted mean difference; SMD: standard mean difference; CI: confidence interval; d: days; mon: months